Clindamycin/tretinoin - Ortho Dermatologics
Alternative Names: Acnatac; Acnex; CLin-RA; CLIN/RA Gel (1.2% clindamycin phosphate and crystalline 0.025% tretinoin aqueous gel) - Meda; Clindamycin/tretinoin gel - Meda; Tretinoin/clindamycin gel - Ortho Dermatologics; ZianaLatest Information Update: 31 Jul 2019
At a glance
- Originator Dow Pharmaceutical Sciences
- Developer Meda
- Class Antiacnes; Antibacterials; Keratolytics; Lincosamides; Retinoids; Small molecules
- Mechanism of Action Protein 50S ribosomal subunit inhibitors; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acne vulgaris
Most Recent Events
- 31 Jul 2019 Clindamycin/tretinoin is not yet available for Acne vulgaris in Austria, Bulgaria, Cyprus, Germany, Iceland, Italy, Romania, Slovakia (Topical)
- 08 May 2019 Launched for Acne vulgaris in Poland, prior May 2019 (Topical)
- 11 Feb 2019 Chemical structure information added